|
|
|
LifeScienceHistory.com - Check us out on Instagram
New Jersey Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing New JerseyLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Pacira Pharmaceuticals
| | | Phone: | (973) 254-3560 | Year Established: | 1989 | Ticker: | NASDAQ | Exchange: | PCRX | Main Contact: | Robert Weiland, CCO | | Other Contacts: | Matthew Lehmann, VP, Marketing – Emerging Therapies Thomas Sluby, VP, Sales Vladimir Kharitonov, Ph.D., VP, R&D David St. Peter, MD, FHM, VP, Medical Affairs Scott Braunstein, MD, COO James B. Jones, MD, PharmD, Senior VP & CMO Taunia Markvicka, PharmD, MBA, Senior VP & CCO Dave Stack, Chairman & CEO James S. Scibetta, President James B. Jones, MD, PharmD, Senior VP & CMO Charles A. Reinhart, III, CFO Richard Scranton, MD, CSO
| | Company Description | Pacira Pharmaceuticals (formerly DepoTech and SkyePharma) is an emerging specialty pharmaceutical company focused on the clinical and commercial development of new products that meet the needs of acute care practitioners and their patients. The company's current emphasis is the development of non-opioid products for postsurgical pain control, and its lead product, EXPAREL (bupivacaine liposome injectable suspension), was approved for administration into the surgical site to produce postsurgical analgesia by the U.S. Food and Drug Administration in October 2011. EXPAREL and two other commercially available products utilize the Pacira proprietary product delivery technology DepoFoam®, a unique platform that encapsulates drugs without altering their molecular structure and then releases them over a desired period of time. | |
|
|
|
|
|